Amanta Healthcare IPO has created a massive buzz in the stock market with record-breaking subscription levels and high investor demand. From allotment status to Grey Market Premium (GMP) and listing date, here’s everything you need to know before the company makes its debut on the NSE and BSE.
About Amanta Healthcare Ltd.
Amanta Healthcare Ltd., established in 1994, is a leading pharmaceutical manufacturer specializing in sterile liquid formulations. The company produces:
- Intravenous (IV) fluids
- Ophthalmic products
- Respiratory care medicines
With ISO and WHO-GMP-certified manufacturing facilities in Hariyala, Kheda (Gujarat), the company has built strong credibility in both domestic and international markets.
Amanta Healthcare IPO Details
The Amanta Healthcare IPO opened with great investor enthusiasm. Below are the complete details:
- IPO Size: ₹126 crore (Fresh issue of 1 crore shares)
- Price Band: ₹120 – ₹126 per share
- Lot Size: 119 shares (Minimum application amount ~₹14,994 at upper band)
- IPO Type: 100% Fresh Issue (no OFS)
- Promoter Holding:
- Pre-IPO: 85.6%
- Post-IPO: 63.56%
The reduction in promoter holding improves free float, which increases stock liquidity for investors post-listing.
Amanta Healthcare IPO Timeline
| Event | Date |
|---|---|
| IPO Opened | September 1, 2025 |
| IPO Closed | September 3, 2025 |
| Allotment Date | September 4, 2025 |
| Refunds Initiated | September 5 or 8, 2025 |
| Shares Credited to Demat | September 5 or 8, 2025 |
| Listing Date | September 8 or 9, 2025 |
Amanta Healthcare IPO Allotment Status
The Amanta Healthcare IPO allotment status was finalized on September 4, 2025. Investors can check allotment using the following methods:
- Registrar (MUFG Intime India) – via PAN, application number, or DP/Client ID.
- BSE IPO Portal – select “Equity”, choose Amanta Healthcare IPO, and enter PAN/application details.
- NSE Portal – under IPO section, by entering PAN or bid details.
👉 If you are not allotted shares, refunds will be initiated, and the amount will be credited back to your bank account.
Use of IPO Proceeds
The company plans to use the funds from the IPO as follows:
- ₹70 crore → New SteriPort line at Hariyala
- ₹30.13 crore → New SVP line
- ₹25.87 crore → General corporate purposes
This clear allocation demonstrates a focus on expansion and operational growth, which is likely to enhance profitability in the coming years.
Amanta Healthcare IPO Listing Date
The Amanta Healthcare IPO listing date is scheduled for September 8 or 9, 2025 on both NSE and BSE.
Given the high over subscription and positive GMP trends, investors are expecting a strong market debut, although actual listing gains may vary depending on broader market conditions.
Market Outlook
- High Subscription Levels: Oversubscription of 82× signals strong institutional and retail confidence.
- Positive Grey Market Sentiment: GMP suggests a possible 6–8% listing premium.
- Healthcare Sector Demand: With rising demand for IV fluids, injectables, and sterile formulations, Amanta is well-positioned.
- Long-Term Play: While short-term gains may be limited, the company’s expansion strategy makes it attractive for long-term investors.
Should You Invest in Amanta Healthcare IPO?
- For Listing Gains: Moderate upside is expected based on GMP.
- For Long-Term Investors: The company’s strong fundamentals, capacity expansion, and global certifications make it a compelling healthcare stock.
Final Thoughts
The Amanta Healthcare IPO has been a blockbuster in terms of subscription, allotment demand, and investor participation. While allotment chances for retail investors are low due to over subscription, those who receive shares could benefit from a positive listing. Long-term investors may also find value in holding, given the company’s growth-driven use of funds and leadership in the sterile formulations segment.
Subscription
| Investor | 01 Sep 2025 | 02 Sep 2025 | 03 Sep 2025 |
|---|---|---|---|
| Anchor | 0 | 0 | 0 |
| QIB | 0.04 | 0.53 | 35.86 |
| Non-Institutional | 5.82 | 36.41 | 209.13 |
| BNII | 4.24 | 30.03 | 226.13 |
| SNII | 8.99 | 49.15 | 175.96 |
| Retail | 6.72 | 23.35 | 54.96 |
| Total | 4.62 | 19.63 | 82.60 |
GMP Trend:
| Date | GMP |
|---|---|
| 01 Sep 2025 | ₹25 |
| 02 Sep 2025 | ₹12 |
| 03 Sep 2025 | ₹8.5(6.75%) |
It should be noted that IPO GMP is subject to extreme volatility, so an investment decision based solely on Patel Retail IPO GMP will prove risky. Therefore, before to investing, consider all factors and make the right investment decision whether to invest in Patel Retail IPO or not.
How to Check IPO Allotment Status:
MUFG Intime India
To check IPO allotment status, follow the steps below:
- Click on the below allotment status check button.
- Select Company Name.
- Enter your PAN Number, Application Number or DP Client ID (Anyone).
- Click on Search.
NSE Website
To check IPO allotment status, follow the steps below:
- Click on the below allotment status check button.
- Select Company Name.
- Enter your PAN Number, Application Number or DP Client ID (Anyone).
- Click on Search.
BSE Webiste
To check IPO allotment status, follow the steps below:
- Click on the below allotment status check button.
- Select Company Name.
- Enter your PAN Number, Application Number or DP Client ID (Anyone).
- Click on Search.
📌 Stock Market Disclaimer
- Disclaimer: This post is for informational and educational purposes only and does not constitute financial advice or a recommendation to buy/sell any stock or share. Investing in the stock market involves risk. Past performance is not indicative of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.
- The information provided on this platform is for educational and informational purposes only. It should not be considered as investment advice, stock recommendations, or financial guidance.
- ⚠️ Stock Market Investments
- Investing in equities, derivatives, mutual funds, and other financial instruments involves market risks, volatility, and the possibility of capital loss.
- Past performance of stocks or indices is not indicative of future returns.
- Always conduct your own research or consult a SEBI-registered financial advisor before making investment decisions.
- ⚠️ IPO (Initial Public Offerings)
- IPO details, issue size, subscription data, and allotment status shared here are based on publicly available information from company filings, stock exchanges, and merchant bankers.
- Investing in IPOs carries risks including listing volatility, business uncertainties, and sector performance dependency.
- Neither acceptance of applications nor allotment guarantees profits. Investors should evaluate their risk appetite before subscribing.
- ⚠️ GMP (Grey Market Premium)
- Grey Market Premium (GMP) is an unofficial and unregulated indicator of expected IPO listing price.
- GMP data is collected from market observers and informal trading circles; it does not have any legal or SEBI recognition.
- GMP values are highly speculative and may differ significantly from actual listing prices. Investors should not rely solely on GMP while taking investment decisions.
- ✅ General Advisory
- We do not provide any buy/sell/hold recommendations.
- Readers and investors are solely responsible for their investment actions and decisions.
- This platform, its authors, and affiliates are not liable for any direct or indirect financial loss arising from the use of this information.
- 🔒 Always invest responsibly and diversify your portfolio.
Open Demat Account
by Mirae Asset (m,Stock)
